Equities

Innova Captab Ltd

INNOVACAP:NSI

Innova Captab Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)794.90
  • Today's Change21.90 / 2.83%
  • Shares traded86.71k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 11:02 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments84118967
Total Receivables, Net3,3712,9702,130
Total Inventory1,4661,1811,284
Prepaid expenses3459--
Other current assets, total8626309
Total current assets5,7984,4253,791
Property, plant & equipment, net6,8111,8701,659
Goodwill, net167167167
Intangibles, net8.967.734.53
Long term investments0.010.197.75
Note receivable - long term7.321242
Other long term assets21355981
Total assets13,2097,0445,755
LIABILITIES
Accounts payable1,7971,5851,448
Accrued expenses137803.50
Notes payable/short-term debt2389790
Current portion long-term debt/capital leases107351,312
Other current liabilities, total37696181
Total current liabilities2,6552,7762,945
Total long term debt2,1051,356679
Total debt2,4512,3701,992
Deferred income tax483921
Minority interest------
Other liabilities, total9110924
Total liabilities4,9004,2793,669
SHAREHOLDERS EQUITY
Common stock572480120
Additional paid-in capital3,777----
Retained earnings (accumulated deficit)3,9402,6461,966
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total19(361)--
Total equity8,3092,7652,086
Total liabilities & shareholders' equity13,2097,0445,755
Total common shares outstanding574848
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.